$BSX 3 SEC Filings

Filed On	Filing
24 Feb 2026	Form 3: Weber Christophe Pierre, Director No securities owned
24 Feb 2026	Form 3: Smith Cathy R, Director Holds 141 shares of Common Stock
08 Dec 2025	Form 3: O'Connor Padraig Andrew, EVP, Global Operations Holds 3,885 shares of Common Stock
30 Jun 2025	Form 3: Monson Jonathan, EVP and CFO Holds 34,727 shares of Common Stock
06 Jan 2025	Form 3: O'Sullivan Miriam, SVP, Chief HR Officer Holds 11,956 shares of Common Stock
30 Jul 2024	Form 3: Habiger David C, Director Holds 140 shares of Common Stock
13 May 2024	Form 3: Pegus Cheryl, Director No securities owned
05 Mar 2024	Form 3: Woodworth Emily, SVP, Global Controller and CAO Holds 3,861 shares of Common Stock
30 Jun 2023	Form 3: Morano Susan E, Director No securities owned
30 Jun 2023	Form 3: Mega Jessica L, Director No securities owned
28 Jun 2021	Form 3: Wichmann David S, Director No securities owned
17 Jun 2021	Form 3: Brown Vance R, SVP, GC and Corp. Secretary Holds 27,436 shares of Common Stock
30 Sep 2020	Form 3: Boston Scientific Corp, 10% owner · Pulmonx Corp Holds 141 shares of Common Stock
09 Jul 2020	Form 3: Olson Scott, SVP & Pres, Rhythm Management Holds 10,578 shares of Common Stock
18 Feb 2020	Form 3: Scanlon Meghan, SVP,Pres,Urology Pelvic Health Holds 7,321 shares of Common Stock
01 Jul 2019	Form 3: Monson Jonathan, VP, Corp Controller and CAO Holds 29,599 shares of Common Stock
03 Apr 2018	Form 3: Eddy Jodi Euerle, SVP and CIO Holds 14,203 shares of Common Stock
08 Jan 2018	Form 3: Wang Xin Warren, SVP and Pres, Asia Pacific Holds 92,531 shares of Common Stock
04 Dec 2017	Form 3: Ralls-Morrison Desiree, SVP, GC and Secretary No securities owned
10 Jan 2017	Form 3: Meredith Ian T, EVP/ Global Chief Medical Offi No securities owned

Comments